Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 4, 2009, Pages 843-848

  Patel, Apurva ^a   Anraku, Masaki ^a   Darling, Gail E ^a   Shepherd, Frances A ^a   Pierre, Andrew F ^a   Waddell, Thomas K ^a   Keshavjee, Shaf ^a   de Perrot, Marc ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; NAVELBINE; PEMETREXED; RALTITREXED;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DEATH; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; INFERIOR CAVA VEIN; LOBECTOMY; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SURGICAL RISK; TREATMENT OUTCOME; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOADJUVANT THERAPY; PLEURAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; RISK FACTORS; SURVIVAL RATE; VENA CAVA, INFERIOR; VENOUS THROMBOEMBOLISM;

EID: 70349088682     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.02.028     Document Type: Article

References (23)

1. Zurawska U., Parasuraman S., and Goldhaber S.Z. Prevention of pulmonary embolism in general surgery patients. Circulation 115 (2007) 302-307
2. Kakkar V.V., Corrigan T.P., and Fossard D.P. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet 2 (1975) 45-51
3. Fischer S., Darling G., Pierre A.F., Sun A., Leighl N., Waddell T.K., et al. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet. Eur J Cardiothorac Surg 33 (2008) 1129-1134
4. Uy K.L., Darling G., Xu W., Yi Q.L., De Perrot M., Pierre A.F., et al. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. J Thorac Cardiovasc Surg 134 (2007) 188-193
5. Blackstone E.H. Comparing apples and oranges. J Thorac Cardiovasc Surg 123 (2002) 8-15
6. Rubin D.B. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Statist Med 26 (2007) 20-36
7. Mason D.P., Quader M.A., Blackstone E.H., Rajeswaran J., DeCamp M.M., Murthy S.C., et al. Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome. J Thorac Cardiovasc Surg 131 (2006) 711-718
8. Sugarbaker D.J., Jaklitsch M.T., Bueno R., Richards W., Lukanich J., Mentzer S.J., et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128 (2004) 138-146
9. Dentali F., Malato A., Ageno W., Imperatori A., Cajozzo M., Rotolo N., et al. Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. J Thorac Cardiovasc Surg 135 (2008) 705-706
10. Bergqvist D., Agnelli G., Cohen A.T., Eldor A., Nilsson P.E., Le Moigne-Amrani A., et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346 (2002) 975-980
11. Kakkar A.K., Brenner B., Dahl O.E., Eriksson B.I., Mouret P., Muntz J., et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 372 (2008) 31-39
12. Geerts W.H., Bergqvist D., Pineo G.F., Heit J.A., Samama C.M., Lassen M.R., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 6 Suppl (2008) 381S-453S
13. Lyman G.H., Khorana A.A., Falanga A., Clarke-Pearson D., Flowers C., Jahanzeb M., et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25 (2007) 5490-5505
14. Blom J.W., Vanderschoot J.P., Oostindiër M.J., Osanto S., van der Meer F.J., and Rosendaal F.R. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4 (2006) 529-535
15. Chew H.K., Davies A.M., Wun T., Harvey D., Zhou H., and White R.H. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 6 (2008) 601-608
16. Berczi V., Bottomley J.R., Thomas S.M., Taneja S., Gaines P.A., and Cleveland T.J. Long-term retrievability of IVC filters: should we abandon permanent devices?. Cardiovasc Intervent Radiol 30 (2007) 820-827
17. Ribeiro A., Lindmarker P., Johnsson H., Juhlin-Dannfelt A., and Jorfeldt L. Pulmonary embolism: one-year follow-up with echocardiography Doppler and five-year survival analysis. Circulation 99 (1999) 1325-1330
18. Ribeiro A., Lindmarker P., Johnsson H., Juhlin-Dannfelt A., and Jorfeldt L. Pulmonary embolism: a follow-up study of the relation between the degree of right ventricle overload and the extent of perfusion defects. J Intern Med 245 (1999) 601-610
19. de Perrot M., Fadel E., McRae K., Tan K., Slinger P., Paul N., et al. Evaluation of persistent pulmonary hypertension after acute pulmonary embolism. Chest 132 (2007) 780-785
20. Tunariu N., Gibbs S.J., Win Z., Gin-Sing W., Graham A., Gishen P., et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 48 (2007) 680-684
21. Sorensen H.T., Mellemkjaer L., Olsen J.H., and Baron J.A. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343 (2000) 1846-1850
22. Shepherd F., Hasan B., Hicks L., Cheung M., Leighl N., Winton T., et al. Venous thromboembolism (VTE) and non-small cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trials. Eur J Cancer 4 Suppl (2007) 361 (Abst 6516)
23. Winton T., Livingston R., Johnson D., Rigas J., Johnston M., Butts C., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352 (2005) 2589-2597